tibolone has been researched along with Amentia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Cho, Y; Choi, S; Han, M; Lee, G; Park, SM | 1 |
| Kimmig, R; Schmidt, M | 1 |
1 review(s) available for tibolone and Amentia
| Article | Year |
|---|---|
[The benefits and risks of hormonal replacement therapy--an update].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors | 2006 |
1 other study(ies) available for tibolone and Amentia
| Article | Year |
|---|---|
Association of tibolone and dementia risk: a cohort study using Korean claims data.
Topics: Administrative Claims, Healthcare; Aged; Cohort Studies; Databases, Factual; Dementia; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Republic of Korea; Risk Factors | 2021 |